Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01106664 · ClinicalTrials.gov registry record · Phase 1
ONO-7746 Study in Healthy Adult Subject
A Phase 1 study, sponsored by Ono Pharmaceutical Co..
- Completed
- Registry status
- Phase 1
- Development phase
- 72
- Enrollment target
NCT01106664 is a Phase 1 study that has completed, run by Ono Pharmaceutical Co.. The registered enrollment target is 72 participants.
The verdict
NCT01106664, a Phase 1 study, has completed, sponsored by Ono Pharmaceutical Co..
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 72 participants
- Enrollment target
Study Summary
The primary objective of this study is to evaluate the safety and tolerability of NON-7746 in healthy adult subjects. The secondary objectives are to characterize the pharmacokinetic and pharmacodynamic profiles of ONO-7746 and to evaluate the food effect on the PK profile of ONO-7746 when administered with or without a meal.
Interventions
- DRUG ONO-7746
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2010-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01106664
The ClinicalTrials.gov registry entry for NCT01106664 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ono Pharmaceutical Co., which has 17 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ONO-7746 is the first listed.
NCT01106664 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01106664 about?
NCT01106664 is a clinical study titled "ONO-7746 Study in Healthy Adult Subject". The primary objective of this study is to evaluate the safety and tolerability of NON-7746 in healthy adult subjects. The secondary objectives are to characterize the pharmacokinetic and pharmacodynamic profiles of ONO-7746 and to evaluate the food effect on the PK profile of ONO-7746 when administe...
What is the current status of trial NCT01106664?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 72 participants. The study started on 2010-04.
What interventions are being tested in trial NCT01106664?
The interventions under investigation include: ONO-7746 (DRUG).
Who is sponsoring clinical trial NCT01106664?
This trial is sponsored by Ono Pharmaceutical Co., which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.